![](/img/cover-not-exists.png)
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor
Li, Dong, March, Michael E., Gutierrez-Uzquiza, Alvaro, Kao, Charlly, Seiler, Christoph, Pinto, Erin, Matsuoka, Leticia S., Battig, Mark R., Bhoj, Elizabeth J., Wenger, Tara L., Tian, Lifeng, RobinsonLanguage:
english
Journal:
Nature Medicine
DOI:
10.1038/s41591-019-0479-2
Date:
July, 2019
File:
PDF, 4.36 MB
english, 2019